Innate immunity: The missing link in neuroprotection and neurodegeneration?

Nature Reviews Neuroscience

Volumn 3, Issue 3, 2002, Pages 216-227

  Nguyen, Minh Dang ^a   Julien, Jean Pierre ^a   Rivest, Serge ^b  

^a MONTREAL GENERAL HOSPITAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; CYTOKINE; DROSOPHILA PROTEIN; MEMBRANE PROTEIN; TOLL LIKE RECEPTOR;

ANIMAL; CELL SURVIVAL; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM INFECTION; DEGENERATIVE DISEASE; ENCEPHALITIS; HUMAN; IMMUNE SYSTEM; IMMUNOLOGY; METABOLISM; NERVE REGENERATION; PATHOPHYSIOLOGY; REVIEW; VIROLOGY;

ANIMALS; CELL SURVIVAL; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM INFECTIONS; CYTOKINES; DROSOPHILA PROTEINS; ENCEPHALITIS; HUMANS; IMMUNE SYSTEM; MEMBRANE GLYCOPROTEINS; NERVE REGENERATION; NEURODEGENERATIVE DISEASES; RECEPTORS, CELL SURFACE; TOLL-LIKE RECEPTORS;

EID: 0036518997     PISSN: 1471003X     EISSN: 14710048     Source Type: Journal    
DOI: 10.1038/nrn752     Document Type: Article

References (101)

1. Anderson, K. V. Toll signaling pathways in the innate immune response. Curr. Opin. Immunol. 12, 13-19 (2000).
2. Wright, S. D. Toll, a new piece in the puzzle of innate immunity. J. Exp. Med. 189, 605-609 (1999).
3. Akira, S., Takeda, K. & Kaisho, T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nature Immunol. 2, 675-680 (2001).
4. Muzio, M., Polentarutti, N., Bosisio, D., Prahladan, M. K. & Mantovani, A. Toll-like receptors: a growing family of immune receptors that are differentially expressed and regulated by different leukocytes. J. Leukoc. Biol. 67, 450-456 (2000).
5. Beutler, B. Tlr4: central component of the sole mammalian LPS sensor. Curr. Opin. Immunol. 12, 20-26 (2000).
6. Poltorak, A. et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282, 2085-2088 (1998).
7. Takeuchi, O. et al. Differential roles of TLR2 and TLR4 in recognition of Gram-negative and Gram-positive bacterial cell wall components. Immunity 11, 443-451 (1999).
8. Hayashi, F. et al. The innate immune response to bacterial flagellin is mediated by Toll-like receptor. Nature 410, 1099-1103 (2001).
9. Hemmi, H. et al. A Toll-like receptor recognizes bacterial DNA. Nature 408, 740-745 (2000).
10. Alexopoulou, L., Holt, A. C., Medzhitov, R. & Flavell, R. A. Recognition of double-stranded RNA and activation of NF- κB by Toll-like receptor. Nature 413, 732-738 (2001).
11. Ozinsky, A. et al. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between Toll-like receptors. Proc. Natl Acad. Sci. USA 97, 13766-13771 (2000).
12. Chu, W. M. et al. JNK2 and IKKβ are required for activating the innate response to viral infection. Immunity 11, 721-731 (1999).
13. Delhase, M., Hayakawa, M., Chen, Y & Karin, M. Positive and negative regulation of I κB kinase activity through IKKβ subunit phosphorylation. Science 284, 309-313 (1999).
14. Hu, Y. et al. Abnormal morphogenesis but intact IKK activation in mice lacking the IKKα subunit of IκB kinase. Science 284, 316-320 (1999).
15. Lacroix, S., Feinstein, D. & Rivest, S. The bacterial endotoxin lipopolysaccharide has the ability to target the brain in upregulating its membrane CD14 receptor within specific cellular populations. Brain Pathol. 8, 625-640 (1998).
16. Laflamme, N. & Rivest, S. Toll-like receptor 4: the missing link of the cerebral innate immune response triggered by circulating Gram-negative bacterial cell wall components. FASEB J. 15, 155-163 (2001).
17. Laflamme, N., Souci, G. & Rivest, S. Circulating cell wall components derived from Gram-negative and not Gram- positive bacteria cause a profound transcriptional activation of the gene encoding toll-like receptor 2 in the CNS. J. Neurochem. 70, 648-657 (2001).
18. Brochu, S., Olivier, M. & Rivest, S. Neuronal activity and transcription of proinflammatory cytokines, IκBα, and iNOS in the mouse brain during acute endotoxemia and chronic infection with Trypanosoma brucei brucei. J. Neurosci. Res. 57, 801-816 (1999).
19. Nadeau, S. & Rivest, S. Regulation of the gene encoding tumor necrosis factor α in the rat brain and pituitary in response to different models of systemic immune challenge. J. Neuropathol. Exp. Neurol. 58, 61-77 (1999).
20. Nadeau, S. & Rivest, S. Role of microglial-derived tumor necrosis factor in mediating CD14 transcription and NF-kB activity in the brain during endotoxemia. J. Neurosci. 20, 3456-3468 (2000).
21. Nadeau, S. & Rivest, S. The complement system is an integrated part of the natural innate immune response in the brain. FASEB J. 15, 1410-1412 (2001).
22. Quan, N., Whiteside, M. & Herkenham, M. Time course and localization patterns of interleukin-1 β mRNA expression in the brain and pituitary after peripheral administration of lipopolysaccharide. Neuroscience 83, 281-293 (1997).
23. Thibeault, I., Laflamme, N. & Rivest, S. Regulation of the gene encoding the monocyte chemoattractant protein 1 (MCP-1) in the mouse and rat brain in response to circulating LPS and proinflammatory cytokines. J. Comp. Neurol. 434, 461-477 (2001).
24. Fearns, C. & Loskutoff, D. J. Role of tumor necrosis factor a in induction of murine CD14 gene expression by lipopolysaccharide. Infect. Immun. 65, 4822-4831 (1997).
25. Fearns, C. & Ulevitch, R. J. Effect of recombinant interleukin-1 β on murine CD14 gene expression in vivo. Shock 9, 157-163 (1998).
26. Zekki, H., Feinstein, D. L. & Rivest, S. The clinical course of experimental autoimmune encephalomyelitis is associated with a profound and sustained transcriptional activation of the genes encoding toll-like receptor 2 and CD14 in the mouse CNS. Brain Pathol. (in the press).
27. Nguyen, M. D., Julien, J.-P & Rivest, S. Induction of proinflammatory molecules in mice with amyotrophic lateral sclerosis: no requirement for proapoptotic interleukin-1 β in neurodegeneration. Ann. Neurol. 50, 630-639 (2001).
28. Castano, A., Herrera, A. J., Cano, J. & Machado, A. Lipopolysaccharide intranigral injection induces inflammatory reaction and damage in nigrostriatal dopaminergic system. J. Neurochem. 70, 1584-1592 (1998).
29. Kim, W. G. et al. Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia. J. Neurosci. 20, 6309-6316 (2000).
30. Eklind, S. et al. Bacterial endotoxin sensitizes the immature brain to hypoxic-ischaemic injury. Eur. J. Neurosci. 13, 1101-1106 (2001).
31. Herx, L. M., Rivest, S. & Yong, V. W. Central neivous system-initiated inflammation and neurotropism in trauma: IL-1 β is required for the production of ciliary neurotrophic factor. J. Immunol. 165, 2232-2239 (2000).
32. Dusart, I. & Schwab, M. E. Secondary cell death and the inflammatory reaction after dorsal hemisection of the rat spinal cord. Eur. J. Neurosci. 6, 712-724 (1994).
33. Frank, M. & Wolburg, H. Cellular reactions at the lesion site after crushing of the rat optic nee. Glia 16, 227-240 (1996).
34. Bandtlow, C. E. et al. Regional and cellular codistribution of interleukin-1 β and nerve growth factor mRNA in the adult rat brain. J. Cell Biol. 111, 1701-1711 (1990).
35. DeKosky, S. T. et al. Interleukin-1 receptor antagonist suppresses neurotrophin response in injured rat brain. Ann. Neurol. 39, 123-127 (1996).
36. Mason, J. L., Suzuki, K., Chaplin, D. D. & Matsushima, G. K. Interleukin-1 β promotes repair of the CNS. J. Neurosci. 21, 7046-7052 (2001).
37. Venters, H. D. et al. A new mechanism of neurodegeneration: a proinflammatory cytokine inhibits receptor signaling by a survival peptide. Proc. Natl Acad. Sci. USA 96, 9879-9884 (1999).
38. Arnett, H. A. et al. TNFα promotes proliferation of oligodendrocyte progenitors and remyelination. Nature Neurosci. 4, 1116-1122 (2001).
39. Jensen, M. B., Hegelund, I. V., Lomholt, N. D., Finsen, B. & Owens, T. IFNγ enhances microglial reactions to hippocampal axonal degeneration. J. Neurosci. 20, 3612-3621 (2000).
40. Pouly, S., Becher, B., Blain, M. & Antel, J. P Interferon-γ modulates human oligodendrocyte susceptibility to Fas-mediated apoptosis. J. Neuropathol. Exp. Neurol. 59, 280-286 (2000).
41. Pasinetti, G. M. Cyclooxygenase and inflammation in Alzheimer's disease: experimental approaches and clinical interventions. J. Neurosci. Res. 54, 1-6 (1998).
42. Gonzalez-Scarano, F. & Baltuch, G. Microglia as mediators of inflammatory and degenerative diseases. Annu. Rev. Neurosci. 22, 219-240 (1999).
43. Julien, J.-P. Amyotrophic lateral sclerosis: unfolding the toxicity of the misfolded. Cell 104, 581-591 (2001)
44. Stoll, G., Jung, S., Jander, S., van der Meide, P. & Hartung, H. P. Tumor necrosis factor-α in immune-mediated demyelination and Wallerian degeneration of the rat peripheral nervous system. J. Neuroimmunol. 45, 175-182 (1993).
45. Martin-Villalba, A. et al. Therapeutic neutralization of CD95- ligand and TNF attenuates brain damage in stroke. Cell Death Differ. 8, 679-686 (2001).
46. Robertson, J. et al. Apoptotic death of neurons exhibiting peripherin aggregates is mediated by the proinflammatory cytokine tumor necrosis factor-α. J. Cell Biol. 155, 217-226 (2001).
47. Allan, S. M. & Rothwell, N. J. Cytokines and acute neurodegeneration. Nature Rev. Neurosci. 2, 734-744 (2001).
48. Hickey, W. F. & Kimura, H. Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. Science 239, 290-292 (1988).
49. Mattson, M. P, Pedersen, W. A., Duan, W., Culmsee, C. & Camandola, S. Cellular and molecular mechanisms underlying perturbed energy metabolism and neuronal degeneration in Alzheimer's and Parkinson's diseases. Ann. NY Acad. Sci. 893, 154-175 (1999).
50. Albers, D. S. & Beal, M. F. Mitochondrial dysfunction and oxidative stress in aging and neurodegenerative disease. J. Neural Transm. 59, 133-154 (2000).
51. Neumann, H., Cavalie, A., Jenne, D. E. & Wekerle, H. Induction of MHC class I genes in neurons. Science 269, 549-552 (1995).
52. Neumann, H., Schmidt, H., Cavalie, A., Jenne, D. & Wekerle, H. Major histocompatibility complex (MHC) class I gene expression in single neurons of the central nervous system: differential regulation by interferon (IFN)-γ and tumor necrosis factor (TNF)-α. J. Exp. Med. 185, 305-316 (1997).
53. Corriveau, R. A., Huh, G. S. & Shatz, C. J. Regulation of class I MHC gene expression in the developing and mature CNS by neural activity. Neuron 21, 505-520 (1998).
54. Darnell, R. B. Immunologic complexity in neurons. Neuron 21, 947-950 (1998).
55. Musunuru, K. & Darnell, R. B. Paraneoplastic neurologic disease antigens: RNA-binding proteins and signaling proteins in neuronal degeneration. Annu. Rev. Neurosci. 24, 239-262 (2001).
56. Solimena, M. & De Camilli, P Synaptic autoimmunity and the Salk factor. Neuron 28, 309-310 (2000).
57. Whitney, K. D. & McNamara, J. O. Autoimmunity and neurological disease: antibody modulation of synaptic transmission. Annu. Rev. Neurosci. 22, 175-195 (1999).
58. Chen, S. et al. Experimental destruction of substantia nigra initiated by Parkinson disease immunoglobulins. Arch. Neurol. 55, 1075-1080 (1998).
59. He, X. P. et al. Glutamate receptor GluR3 antibodies and death of cortical cells. Neuron 20, 153-163 (1998).
60. Engelhardt, J. I., Siklos, L., Komuves, L., Smith, R. G. & Appel, S. H. Antibodies to calcium channels from ALS patients passively transferred to mice selectively increase intracellular calcium and induce ultrastructural changes in motoneurons. Synapse 20, 185-199 (1995).
61. Engelhardt, J. I. et al. Stereotaxic injection of IgG from patients with Alzheimer disease initiates injury of cholinergic neurons of the basal forebrain. Arch. Neurol. 57, 681-686 (2000).
62. Buckanovich, R. J. & Darnell, R. B. The neuronal RNA binding protein Nova-1 recognizes specific RNA targets in vitro and in vivo. Mol. Cell. Biol. 17, 3194-3201 (1997).
63. Buckanovich, R. J., Yang, Y. Y & Darnell, R. B. The onconeural antigen Nova-1 is a neuron-specific RNA-binding protein, the activity of which is inhibited by paraneoplastic antibodies. J. Neurosci. 16, 1114-1122 (1996).
64. Buckanovich, R. J., Posner, J. B. & Darnell, R. B. Nova, the paraneoplastic Ri antigen, is homologous to an RNA- binding protein and is specifically expressed in the developing motor system. Neuron 11, 657-672 (1993).
65. Jensen, K. B. et al. Nova-1 regulates neuron-specific alternative splicing and is essential for neuronal viability. Neuron 25, 359-371 (2000).
66. Alexianu, M. E., Mohamed, A. H., Smith, R. G., Colom, L. V. & Appel, S. H. Apoptotic cell death of a hybrid motoneuron cell line induced by immunoglobulins from patients with amyotrophic lateral sclerosis. J. Neurochem. 63, 2365-2368 (1994).
67. Engelhardt, J. I., Siklos, L. & Appel, S. H. Altered calcium homeostasis and ultrastructure in motoneurons of mice caused by passively transferred anti-motoneuronal IgG. J. Neuropathol. Exp. Neurol. 56, 21-39 (1997).
68. Pullen, A. H. & Humphreys, P. Ultrastructural analysis of spinal motoneurones from mice treated with IgG from ALS patients, healthy individuals, or disease controls. J. Neurol. Sci. 180, 35-45 (2000).
69. Obal, I., Jakab, J. S., Siklos, L. & Engelhardt, J. I. Recruitment of activated microglia cells in the spinal cord of mice by ALS IgG. Neuroreport 12, 2449-2452 (2001).
70. Rogers, S. W. et al. Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis. Science 265, 648-651 (1994).
71. Yang, R. et al. Autoimmunity to munc-18 in Rasmussen's encephalitis. Neuron 28, 375-383 (2000).
72. De Camilli, P. et al. The synaptic vesicle-associated protein amphiphysin is the 128-kD autoantigen of Stiff-Man syndrome with breast cancer. J. Exp. Med. 178, 2219-2223 (1993).
73. Li, L., Hagopian, W. A., Brashear, H. R., Daniels, T. & Lernmark, A. Identification of autoantibody epitopes of glutamic acid decarboxylase in stiff-man syndrome patients. J. Immunol. 152, 930-934 (1994).
74. Butler, M. H. et al. Autoimmunity to gephyrin in Stiff-Man syndrome. Neuron 26, 307-312 (2000).
75. Li, Y. et al. Local-clonal expansion of infiltrating T lymphocytes in chronic encephalitis of Rasmussen. J. Immunol. 158, 1428-1437 (1997).
76. Albert, M. L. et al. Tumor-specific killer cells in paraneoplastic cerebellar degeneration. Nature Med. 4, 1321-1324 (1998).
77. Whitney, K. D., Andrews, P. I. & McNamara, J. O. Immunoglobulin G and complement immunoreactivity in the cerebral cortex of patients with Rasmussen's encephalitis. Neurology 53, 699-708 (1999).
78. Albert, M. L., Austin, L. M. & Darnell, R. B. Detection and treatment of activated T cells in the cerebrospinal fluid of patients with paraneoplastic cerebellar degeneration. Ann. Neurol. 47, 9-17 (2000).
79. Provinciali, L. et al. Immunity assessment in the early stages of amyotrophic lateral sclerosis: a study of virus antibodies and lymphocyte subsets. Acta Neurol. Scand. 78, 449-454 (1988)
80. Lampson, L. A., Kushner, P D. & Sobel, R. A. Major histocompatibility complex antigen expression in the affected tissues in amyotrophic lateral sclerosis. Ann. Neurol. 28, 365-372 (1990).
81. Troost, D., van den Oord, J. J. & Vianney de Jong, J. M. Immunohistochemical characterization of the inflammatory infiltrate in amyotrophic lateral sclerosis. Neuropathol. Appl. Neurobiol. 16, 401-410 (1990).
82. Panzara, M. A. et al. T cell receptor BV gene rearrangements in the spinal cords and cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Neurobiol. Dis. 6, 392-405 (1999).
83. Huber, J. D., Egleton, R. D. & Davis, T. P. Molecular physiology and pathophysiology of tightjunctions in the blood-brain barrier. Trends Neurosci. 24, 719-725 (2001).
84. Su, G. C., Arendash, G. W., Kalaria, R. N., Bjugstad, K. B. & Mullan, M. Intravascular infusions of soluble β-amyloid compromise the blood-brain barrier, activate CNS glial cells and induce peripheral hemorrhage. Brain Res. 818, 105-117 (1999).
85. Dobrogowska, D. H., Lossinsky, A. S., Tarnawski, M. & Vorbrodt, A. W. Increased blood-brain barrier permeability and endothelial abnormalities induced by vascular endothelial growth factor. J. Neurocytol. 27, 163-173 (1998).
86. Zhang, Z. G. et al. VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. J. Clin. Invest. 106, 829-838 (2000).
87. Proescholdt, M. A. et al. Vascular endothelial growth factor (VEGF) modulates vascular permeability and inflammation in rat brain. J. Neuropathol. Exp. Neurol. 58, 613-627 (1999).
88. Oosthuyse, B. et al. Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nature Genet. 28, 131-138 (2001).
89. MacGowan, D. J., Scelsa, S. N. & Waldron, M. An ALS-like syndrome with new HIV infection and complete response to antiretroviral therapy. Neurology 57, 1094-1097 (2001).
90. Moulignier, A., Moulonguet, A., Pialoux, G. & Rozenbaum, W. Reversible ALS-like disorder in HIV infection. Neurology 57, 995-1001 (2001).
91. Jubelt, B. Motor neuron diseases and viruses: poliovirus, retroviruses, and lymphomas. Curr. Opin. Neurol. Neurosurg. 5, 655-658 (1992).
92. Bartfeld, H. et al. Enteroviral-related antigen in circulating immune complexes of amyotrophic lateral sclerosis patients. Intervirology 30, 202-212 (1989).
93. Westarp, M. E. et al. Amyotrophic lateral sclerosis an enigmatic disease with B-cellular and anti-retroviral immune responses. Eur. J. Med. 2, 327-332 (1993).
94. Ferrante, P. et al. HTLV tax-rex DNA and antibodies in idiopathic amyotrophic lateral sclerosis. J. Neurol. Sci. 129, 140-144 (1995).
95. Berger, M. M. et al. Detection and cellular localization of enterovirus RNA sequences in spinal cord of patients with ALS. Neurology 54, 20-25 (2000).
96. Price, R. W. AIDS dementia complex: a complex, slow virus 'model' of acquired genetic neurodegenerative disease. Cold Spring Harb. Symp. Quant. Biol. 61, 759-770 (1996).
97. O'Meara, M. & Ouvrier, R. Viral encephalitis in children. Curr. Opin. Pediatr. 8, 11-15 (1996).
98. Lampe, J., Marino, S., Rethwilm, A. & Aguzzi, A. Degeneration of the cerebellar granule cell layer in transgenic mice expressing genes of human foamy virus. Neuropathol. Appl. Neurobiol. 24, 36-43 (1998).
99. Wellmer, A., Noeske, C., Gerber, J., Munzel, U. & Nau, R. Spatial memory and learning deficits after experimental pneumococcal meningitis in mice. Neurosci. Lett. 296, 137-140 (2000).
100. Koustova, E. et al. LP-BM5 virus-infected mice produce activating autoantibodies to the AMPA receptor. J. Clin. Invest. 107, 737-744 (2001).
101. Schlenker, E. H., Jones, Q. A., Rowland, R. R., Steffen-Bien, M. & Cafruny, W. A. Age-dependent poliomyelitis in mice is associated with respiratory failure and viral replication in the central nervous system and lung. J. Neurovirol. 7, 265-271 (2001).